HP High Court: 'Glucose-D' is a Descriptive Term, Zydus Cannot Claim Monopoly to Restrain Leeford

Shimla, HP - The Himachal Pradesh High Court, in a significant ruling on trademark law, has declined to grant an interim injunction to Zydus Wellness Products Ltd., the owner of the well-known 'Glucon-D' brand. The court, presided over by Justice Sandeep Sharma, held that the defendant, Leeford Healthcare Ltd., could not be restrained from using the marks 'Glucose-D' and 'Glucose-C' as they are descriptive of the product's ingredients and their use is protected under The Trade Marks Act , 1999.

Case Overview

Zydus Wellness Products Ltd. filed a commercial suit against Leeford Healthcare Ltd., alleging trademark infringement, passing off, and copyright violation. Zydus claimed that Leeford’s use of 'Glucose-D' and 'Glucose-C' for its glucose-based energy drinks was deceptively similar to Zydus's registered trademarks 'Glucon-D' and 'Glucon-C'. Zydus argued that Leeford was piggybacking on the immense goodwill and reputation built by the 'Glucon-D' brand since 1933, using similar packaging, colour schemes, and taglines to confuse consumers.

Leeford Healthcare countered that 'Glucose-D' and 'Glucose-C' are generic and descriptive terms, indicating that the product is a glucose powder fortified with Vitamin D or Vitamin C. They argued that such descriptive use is permissible under law and that many other companies, including Dabur and Rasna, use similar terms.

Arguments of the Parties

Zydus Wellness Products Ltd. (Plaintiff): * Deceptive Similarity: Argued that 'Glucose-D' is phonetically, visually, and structurally similar to 'Glucon-D', creating a likelihood of consumer confusion. * Well-Known Mark: Contended that 'Glucon-D' is a well-known trademark with over 58% market share, deserving the highest level of protection. * Trade Dress Infringement: Claimed that Leeford copied essential features of its packaging, including the colour combination, 'Instant Energy' tagline, and the 'Happy Family' motif. * Passing Off: Asserted that Leeford's actions amounted to passing off, aimed at exploiting the goodwill Zydus had built over nine decades.

Leeford Healthcare Ltd. (Defendant): * Descriptive and Generic Use: Maintained that 'Glucose-D' is purely descriptive of the product's ingredients (Glucose + Vitamin D) and is protected under Section 30(2)(a) and Section 35 of The Trade Marks Act . * Plaintiff's Prior Admissions: Highlighted that Zydus's predecessor, while obtaining registration, had told the Trademark Registrar that "‘Gluco’ is common to trade" and that "words GLUCOSE-D and GLUCOSE are common to the trade and no one can have monopoly rights in such descriptive words." * Common to Trade: Provided evidence that numerous manufacturers use 'Glucose-D' and similar packaging elements, making them publici juris (of public right). * Delay and Laches: Pointed out that Zydus waited over 16 months after issuing a cease-and-desist notice in April 2023 before filing the suit, which disentitles them to an interim injunction.

Court's Analysis and Legal Principles Applied

Justice Sandeep Sharma conducted a detailed analysis, emphasizing the principles governing interim injunctions in trademark cases. The court relied heavily on the statutory exceptions to infringement and the plaintiff's own conduct.

On Descriptive Marks: The court found merit in the defendant's argument that 'Glucose-D' is a descriptive term. Citing Section 30(2)(a) of the Act, the judgment noted that the use of a mark indicating the "kind, quality, quantity, intended purpose... or other characteristics of goods" does not constitute infringement.

> "Since the defendant’s product contains both ‘glucose’ and ‘Vitamin D’ and seems to be an honest descriptive use of the main ingredient of the product, it cannot be said to infringe the registered trademark of the plaintiff. The term ‘glucose’ being the key ingredient of the product serves merely as a descriptive indication of its nature and composition."

On Plaintiff's Contradictory Stand: A crucial factor for the court was the plaintiff's previous admission before the Trade Marks Registrar. The court held that the plaintiff was estopped from claiming exclusivity over terms it had previously admitted were "common to trade."

> "By not placing its own stand in front of registrar, plaintiff disentitled itself from grant of discretionary relief under Order XXXIX Rules 1 and 2."

Application of Anti-Dissection Rule: The court affirmed the 'anti-dissection rule,' stating that trademarks must be compared as a whole. It noted that the defendant's product is sold under its registered brand 'Rock-On', which is prominently displayed on the packaging. When viewed holistically, the overall impression of the two products was not found to be confusingly similar.

> "Even though the packaging is a carton box in color green, the product if seen as a whole, prima facie causes no confusion. Therefore, in my view, there was no intention on the part of defendant to play fraud by misrepresenting his goods as the goods of the plaintiff."

Final Decision

The High Court concluded that Zydus had failed to establish a prima facie case for the grant of an interim injunction. The court found that the balance of convenience did not favor Zydus, as an injunction would disrupt Leeford's established business, which has been in the market for over a decade. The potential harm to Zydus, if any, could be compensated with damages later.

While dismissing the application for an injunction, the court directed Leeford Healthcare to maintain detailed accounts of the sales of its 'Glucose-D' and 'Glucose-C' products and furnish them to the plaintiff. The court clarified that its observations were limited to the disposal of the interim application and would not influence the final merits of the case.